Free Trial
→ Before you buy SpaceX shares, consider this alternative approach (From Weiss Ratings) (Ad)tc pixel Free CGNX Stock Alerts

Cognex (CGNX) Financials

Cognex logo
$68.33 +2.24 (+3.39%)
Closing price 05/26/2026 04:00 PM Eastern
Extended Trading
$69.23 +0.90 (+1.32%)
As of 05:03 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for Cognex

Annual Income Statements for Cognex

This table shows Cognex's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 187 144 177 219 204 176 280 216 113 106 114
Consolidated Net Income / (Loss)		 187 144 177 219 204 176 280 216 113 106 114
Net Income / (Loss) Continuing Operations		 108 144 177 219 204 176 280 216 113 106 114
Total Pre-Tax Income 		127 162 266 235 163 187 319 251 135 131 183
Total Operating Income		 122 154 259 221 143 171 315 246 131 115 163
Total Gross Profit		 348 398 579 600 536 605 760 722 601 626 665
Total Revenue		 451 530 766 806 726 811 1,037 1,006 838 915 994
Operating Revenue		 451 530 766 806 726 811 1,037 1,006 838 915 994
Total Cost of Revenue		 103 131 187 206 190 206 277 284 236 289 329
Operating Cost of Revenue		 103 131 187 206 190 206 277 284 236 289 329
Total Operating Expenses		 226 244 320 379 393 434 445 476 471 511 503
Selling, General & Admin Expense		 157 166 221 263 274 268 309 312 339 371 364
Research & Development Expense		 70 78 99 116 119 131 135 141 139 140 139
Other Operating Expenses / (Income)		 - - - - - - 0.00 21 -8.00 0.00 0.00
Total Other Income / (Expense), net		 5.44 8.01 7.60 13 20 16 3.80 4.47 4.65 16 20
Interest & Investment Income		 3.67 7.04 9.54 15 20 13 6.66 6.72 14 14 17
Other Income / (Expense), net		 1.77 0.97 -1.94 -1.28 0.70 3.39 -2.86 -2.25 -9.45 2.45 3.29
Income Tax Expense		 19 18 90 15 -41 11 39 35 22 25 68
Basic Earnings per Share		 $1.08 $0.84 $1.02 $1.27 $1.19 $1.02 $1.59 $1.24 $0.66 $0.62 $0.68
Weighted Average Basic Shares Outstanding		 172.59M 170.68M 173.29M 172.33M 171.19M 173.49M 176.46M 173.41M 172.25M 171.44M 168.05M
Diluted Earnings per Share		 $1.06 $0.83 $0.98 $1.24 $1.16 $1.00 $1.56 $1.23 $0.65 $0.62 $0.68
Weighted Average Diluted Shares Outstanding		 175.98M 174.14M 179.55M 177.41M 175.27M 176.59M 179.92M 174.87M 173.40M 172.61M 169.37M
Weighted Average Basic & Diluted Shares Outstanding		 86.20M 170M 173.20M 172.70M 172.61M 352.06M 347.83M 345.07M 343.27M 169.87M 165.71M
Cash Dividends to Common per Share		 $0.11 $0.15 $0.17 $0.19 $0.21 $2.23 $0.25 $0.27 $0.29 $0.31 $0.33

Quarterly Income Statements for Cognex

This table shows Cognex's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 10/1/2023 12/31/2023 3/31/2024 6/30/2024 9/29/2024 12/31/2024 3/30/2025 6/29/2025 9/28/2025 12/31/2025 4/5/2026
Net Income / (Loss) Attributable to Common Shareholders		 19 11 12 36 30 28 24 41 18 33 52
Consolidated Net Income / (Loss)		 19 11 12 36 30 28 24 41 18 33 52
Net Income / (Loss) Continuing Operations		 19 11 12 36 30 28 24 41 18 33 52
Total Pre-Tax Income 		27 14 18 42 37 36 28 48 63 44 62
Total Operating Income		 31 13 14 38 32 31 26 43 58 35 60
Total Gross Profit		 143 135 142 167 159 158 144 168 187 166 191
Total Revenue		 197 197 211 239 235 230 216 249 277 252 268
Operating Revenue		 197 197 211 239 235 230 216 249 277 252 268
Total Cost of Revenue		 54 62 69 73 75 72 72 81 90 86 77
Operating Cost of Revenue		 54 62 69 73 75 72 72 81 90 86 77
Total Operating Expenses		 112 122 128 128 128 127 118 124 130 131 131
Selling, General & Admin Expense		 82 90 91 93 93 94 84 91 94 95 94
Research & Development Expense		 33 35 37 35 35 33 35 33 35 36 37
Total Other Income / (Expense), net		 -3.64 1.63 3.36 3.11 4.99 4.96 1.71 4.63 5.10 8.80 1.88
Interest & Investment Income		 4.89 1.52 3.12 3.12 3.56 4.17 3.99 4.04 4.20 4.72 4.84
Other Income / (Expense), net		 -8.53 0.11 0.24 -0.01 1.43 0.79 -2.28 0.59 0.90 4.08 -2.95
Income Tax Expense		 8.09 3.13 5.54 5.36 6.96 7.45 4.20 7.55 45 11 10
Basic Earnings per Share		 $0.11 $0.07 $0.07 $0.21 $0.17 $0.17 $0.14 $0.24 $0.11 $0.19 $0.31
Weighted Average Basic Shares Outstanding		 172.17M 172.25M 171.69M 171.57M 171.52M 171.44M 169.27M 167.89M 167.84M 168.05M 166.51M
Diluted Earnings per Share		 $0.11 $0.06 $0.07 $0.21 $0.17 $0.17 $0.14 $0.24 $0.10 $0.20 $0.31
Weighted Average Diluted Shares Outstanding		 173.35M 173.40M 172.59M 172.73M 172.75M 172.61M 170.39M 168.56M 169.32M 169.37M 168.39M
Weighted Average Basic & Diluted Shares Outstanding		 172.14M 343.27M 171.66M 171.50M 171.52M 169.87M 167.86M 167.90M 167.60M 165.71M 166.42M
Cash Dividends to Common per Share		 $0.07 $0.08 $0.08 $0.08 $0.08 $0.08 $0.08 $0.08 $0.08 $0.08 $0.09

Annual Cash Flow Statements for Cognex

This table details how cash moves in and out of Cognex's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 -3.72 28 27 2.72 63 98 -83 -4.79 21 -17 77
Net Cash From Operating Activities		 128 182 224 223 253 242 314 243 113 149 246
Net Cash From Continuing Operating Activities		 128 182 224 223 253 242 314 243 113 149 246
Net Income / (Loss) Continuing Operations		 187 144 177 219 204 176 280 216 113 106 114
Consolidated Net Income / (Loss)		 187 144 177 219 204 176 280 216 113 106 114
Depreciation Expense		 9.87 12 14 18 22 22 17 16 17 21 20
Amortization Expense		 4.94 3.77 3.51 3.18 2.76 5.64 8.55 8.24 6.36 12 9.77
Non-Cash Adjustments To Reconcile Net Income		 -58 19 32 43 57 72 48 106 63 56 45
Changes in Operating Assets and Liabilities, net		 -15 3.63 -1.17 -60 -32 -34 -39 -103 -87 -46 56
Net Cash From Investing Activities		 -11 -122 -106 -11 -157 169 -253 -4.45 32 -39 28
Net Cash From Continuing Investing Activities		 -11 -122 -106 -11 -157 169 -253 -4.45 32 -39 28
Purchase of Property, Plant & Equipment		 -18 -13 -29 -37 -22 -13 -15 -20 -23 -15 -8.74
Acquisitions		 -11 -14 -24 -4.27 -167 1.00 0.00 -5.05 -257 -1.44 0.00
Purchase of Investments		 -687 -752 -637 -782 -1,032 -923 -668 -234 -184 -851 -290
Sale and/or Maturity of Investments		 601 657 584 813 1,063 1,105 431 254 496 828 320
Other Investing Activities, net		 104 -0.11 -0.29 - - - - - 0.00 0.00 6.70
Net Cash From Financing Activities		 -117 -29 -100 -210 -32 -317 -142 -240 -126 -118 -207
Net Cash From Continuing Financing Activities		 -117 -29 -100 -210 -32 -317 -142 -240 -126 -118 -207
Repurchase of Common Equity		 -126 -47 -124 -204 -62 -51 -162 -204 -80 -67 -152
Payment of Dividends		 -18 -25 -29 -32 -35 -391 -43 -46 -49 -52 -55
Issuance of Common Equity		 28 43 55 27 65 126 63 9.86 3.27 0.99 -0.45
Effect of Exchange Rate Changes		 -4.67 -3.35 8.29 - -0.52 2.67 -2.82 -3.37 1.70 -8.25 9.99

Quarterly Cash Flow Statements for Cognex

This table details how cash moves in and out of Cognex's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 10/1/2023 12/31/2023 3/31/2024 6/30/2024 9/29/2024 12/31/2024 3/30/2025 6/29/2025 9/28/2025 12/31/2025 4/5/2026
Net Change in Cash & Equivalents		 218 -193 -64 38 20 -11 -42 36 67 17 -26
Net Cash From Operating Activities		 41 14 14 28 56 51 41 43 87 75 45
Net Cash From Continuing Operating Activities		 41 14 14 28 56 51 41 43 87 75 45
Net Income / (Loss) Continuing Operations		 19 11 12 36 30 28 24 41 18 33 52
Consolidated Net Income / (Loss)		 19 11 12 36 30 28 24 41 18 33 52
Depreciation Expense		 4.38 4.71 5.28 5.19 5.43 5.37 5.31 5.32 4.89 4.77 4.70
Amortization Expense		 0.89 2.58 3.12 2.98 3.26 2.36 2.63 2.53 2.51 2.27 2.53
Non-Cash Adjustments To Reconcile Net Income		 14 19 15 15 13 6.49 10 13 -0.53 22 14
Changes in Operating Assets and Liabilities, net		 2.94 -23 -21 -31 4.49 8.84 -1.29 -19 63 13 -28
Net Cash From Investing Activities		 200 -179 -49 35 -27 2.23 33 -3.97 19 -20 0.79
Net Cash From Continuing Investing Activities		 200 -179 -49 35 -27 2.23 33 -3.97 19 -20 0.79
Purchase of Property, Plant & Equipment		 -5.86 -7.02 -4.06 -4.51 -4.40 -2.07 -2.50 -2.19 -1.45 -2.60 -2.76
Purchase of Investments		 -80 -9.73 -234 -36 -379 -202 -113 -101 -35 -41 -47
Divestitures		 - - - - - - 0.00 - - - 12
Sale and/or Maturity of Investments		 286 94 190 76 356 206 149 100 55 17 39
Net Cash From Financing Activities		 -22 -33 -25 -22 -15 -56 -118 -13 -38 -37 -69
Net Cash From Continuing Financing Activities		 -22 -33 -25 -22 -15 -56 -118 -13 -38 -37 -69
Repurchase of Common Equity		 -10 -20 -9.34 -11 -3.96 -43 -102 - -24 -25 -99
Payment of Dividends		 -12 -13 -13 -13 -13 -14 -14 -13 -13 -14 -14
Issuance of Common Equity		 0.62 -0.01 -2.86 0.99 1.67 1.20 -2.59 0.18 0.26 1.71 44
Effect of Exchange Rate Changes		 -1.38 5.19 -3.33 -2.82 6.75 -8.86 2.43 10 -1.83 -0.77 -2.57

Annual Balance Sheets for Cognex

This table presents Cognex's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 888 1,039 1,288 1,290 1,886 1,801 2,004 1,958 2,018 1,993 2,017
Total Current Assets		 444 526 630 780 607 602 640 718 679 613 697
Cash & Equivalents		 52 80 107 108 171 269 186 181 203 186 263
Short-Term Investments		 296 341 298 427 240 103 137 219 129 60 74
Accounts Receivable		 43 58 127 127 108 131 134 128 117 146 164
Inventories, net		 37 27 68 83 60 61 113 122 162 158 138
Prepaid Expenses		 16 21 31 34 27 37 69 67 68 63 59
Plant, Property, & Equipment, net		 53 54 78 91 89 79 78 80 106 98 86
Total Noncurrent Assets		 390 458 580 418 1,189 1,120 1,286 1,161 1,233 1,281 1,233
Long-Term Investments		 273 324 423 262 433 395 584 454 244 341 305
Goodwill		 81 95 113 113 243 244 242 243 393 385 386
Intangible Assets		 6.32 8.31 13 10 39 16 12 12 113 91 81
Noncurrent Deferred & Refundable Income Taxes		 27 28 27 29 450 435 419 407 400 392 383
Other Noncurrent Operating Assets		 2.61 2.32 2.49 3.93 23 30 30 44 82 72 77
Total Liabilities & Shareholders' Equity		 888 1,039 1,288 1,290 1,886 1,801 2,004 1,958 2,018 1,993 2,017
Total Liabilities		 62 76 192 154 530 539 574 520 513 475 525
Total Current Liabilities		 54 66 113 91 120 132 189 188 152 169 184
Accounts Payable		 7.86 9.83 23 16 18 16 44 27 21 38 50
Accrued Expenses		 33 43 68 60 52 77 92 93 72 72 91
Current Deferred Revenue		 12 8.21 9.42 9.85 14 21 36 41 32 25 21
Current Deferred & Payable Income Tax Liabilities		 0.99 5.19 12 5.06 30 9.38 8.58 18 17 26 9.14
Other Current Liabilities		 - - - 0.00 5.65 8.11 7.79 8.45 9.62 8.85 12
Total Noncurrent Liabilities		 8.40 10 79 63 410 406 385 332 361 306 341
Noncurrent Deferred & Payable Income Tax Liabilities		 5.15 5.36 6.80 8.07 344 329 309 266 274 244 275
Other Noncurrent Operating Liabilities		 3.25 4.87 5.90 3.87 15 28 33 33 69 62 66
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 826 963 1,096 1,135 1,356 1,262 1,430 1,438 1,505 1,518 1,492
Total Preferred & Common Equity		 826 963 1,096 1,135 1,356 1,262 1,430 1,438 1,505 1,518 1,492
Preferred Stock		 - - - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 826 963 1,096 1,135 1,356 1,262 1,430 1,438 1,505 1,518 1,492
Common Stock		 311 375 462 530 640 808 915 980 1,038 1,091 1,139
Retained Earnings		 567 644 669 646 753 488 563 528 513 499 406
Accumulated Other Comprehensive Income / (Loss)		 -52 -56 -35 -41 -37 -34 -48 -69 -45 -73 -53

Quarterly Balance Sheets for Cognex

This table presents Cognex's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 10/2/2022 4/2/2023 7/2/2023 10/1/2023 3/31/2024 6/30/2024 9/29/2024 3/30/2025 6/29/2025 9/28/2025 4/5/2026
Total Assets		 1,900 1,974 1,998 1,990 2,013 2,004 2,063 1,933 2,004 2,003 2,006
Total Current Assets		 787 722 718 847 662 681 672 578 626 671 690
Cash & Equivalents		 266 164 177 396 139 177 197 144 179 246 237
Short-Term Investments		 208 217 191 117 139 112 91 57 49 54 59
Accounts Receivable		 98 147 150 132 141 161 160 164 186 172 187
Inventories, net		 109 127 126 134 171 157 155 152 145 144 136
Prepaid Expenses		 106 68 73 68 71 74 69 61 67 55 71
Plant, Property, & Equipment, net		 79 81 82 83 104 103 103 96 93 90 84
Total Noncurrent Assets		 1,033 1,171 1,198 1,060 1,248 1,220 1,288 1,259 1,284 1,242 1,231
Long-Term Investments		 343 463 463 333 278 266 319 312 324 300 325
Goodwill		 238 242 242 241 386 381 392 390 397 392 383
Intangible Assets		 9.42 11 11 9.99 105 99 103 91 92 87 67
Noncurrent Deferred & Refundable Income Taxes		 405 410 407 403 398 397 395 390 387 384 381
Other Noncurrent Operating Assets		 38 44 75 73 80 78 79 75 83 79 75
Total Liabilities & Shareholders' Equity		 1,900 1,974 1,998 1,990 2,013 2,004 2,063 1,933 2,004 2,003 2,006
Total Liabilities		 511 528 518 501 524 497 496 487 497 513 527
Total Current Liabilities		 161 214 180 170 188 169 171 184 190 169 189
Accounts Payable		 22 27 26 23 27 23 30 43 42 45 60
Accrued Expenses		 64 84 84 79 70 75 77 68 78 87 77
Current Deferred Revenue		 55 58 43 40 40 41 30 40 53 24 34
Current Deferred & Payable Income Tax Liabilities		 12 38 19 19 40 21 24 23 5.48 2.71 6.17
Other Current Liabilities		 8.11 8.18 8.19 7.98 9.80 9.41 9.81 10 11 11 12
Total Noncurrent Liabilities		 350 314 337 332 336 329 325 303 307 344 337
Noncurrent Deferred & Payable Income Tax Liabilities		 272 264 257 253 268 263 257 239 235 275 274
Other Noncurrent Operating Liabilities		 78 50 81 79 68 66 69 64 72 68 64
Commitments & Contingencies		 - - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 1,389 1,446 1,480 1,489 1,489 1,507 1,567 1,446 1,506 1,490 1,479
Total Preferred & Common Equity		 1,389 1,446 1,480 1,489 1,489 1,507 1,567 1,446 1,506 1,490 1,479
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 1,389 1,446 1,480 1,489 1,489 1,507 1,567 1,446 1,506 1,490 1,479
Common Stock		 961 993 1,011 1,024 1,048 1,062 1,077 1,098 1,111 1,123 1,195
Retained Earnings		 511 518 538 534 502 515 528 406 433 412 344
Accumulated Other Comprehensive Income / (Loss)		 -82 -64 -69 -70 -61 -70 -38 -59 -38 -46 -61

Annual Metrics And Ratios for Cognex

This table displays calculated financial ratios and metrics derived from Cognex's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 5.65% 17.52% 44.68% 5.25% -10.01% 11.77% 27.88% -2.99% -16.75% 9.19% 8.73%
EBITDA Growth		 -3.36% 23.46% 60.78% -11.89% -30.61% 20.35% 67.29% -20.40% -46.05% 3.89% 30.16%
EBIT Growth		 -4.13% 25.75% 65.72% -14.43% -34.82% 21.36% 79.53% -21.86% -50.30% -3.08% 41.13%
NOPAT Growth		 -4.19% 32.78% 25.46% 20.41% -13.72% -9.88% 72.04% -23.45% -48.34% -15.03% 9.54%
Net Income Growth		 53.99% -23.19% 22.98% 24.08% -7.02% -13.58% 58.86% -22.99% -47.46% -6.24% 7.79%
EPS Growth		 53.99% -23.19% 18.07% 26.53% -6.45% -13.79% 56.00% -21.15% -47.15% -4.62% 9.68%
Operating Cash Flow Growth		 -21.68% 41.89% 23.20% -0.39% 13.36% -4.31% 29.56% -22.50% -53.61% 32.03% 64.69%
Free Cash Flow Firm Growth		 -43.20% 74.66% -1.73% 12.62% -95.86% 3,011.83% 40.97% -39.55% -256.37% 138.82% 101.18%
Invested Capital Growth		 18.81% 6.51% 23.12% 26.14% 51.14% -3.06% 5.65% 11.75% 58.95% 0.18% -8.70%
Revenue Q/Q Growth		 2.01% 8.24% 6.22% 1.30% -3.14% 7.11% 2.01% -0.46% -4.86% 3.75% 2.33%
EBITDA Q/Q Growth		 -2.35% 8.62% 6.33% -1.58% -13.04% 28.43% -2.12% 0.05% -22.78% 14.65% 3.73%
EBIT Q/Q Growth		 -2.84% 9.42% 6.50% -2.22% -15.50% 34.35% -2.08% 0.24% -26.66% 19.03% 4.89%
NOPAT Q/Q Growth		 -4.10% 10.66% -24.92% 48.87% 17.09% -3.56% -4.06% -0.57% -27.30% 18.41% 2.00%
Net Income Q/Q Growth		 -4.04% 10.48% -25.39% 50.08% 20.66% -5.87% -5.35% 0.83% -28.02% 19.22% 3.92%
EPS Q/Q Growth		 -4.04% 10.48% -28.47% 45.88% 17.17% -7.41% -6.02% 1.65% -28.57% 21.57% 4.62%
Operating Cash Flow Q/Q Growth		 -30.58% 20.59% 4.11% -5.30% -1.56% 6.69% -8.12% 4.75% -31.43% 32.91% 10.58%
Free Cash Flow Firm Q/Q Growth		 -42.98% 17.33% 15.93% -15.15% -96.70% 3,440.33% -9.09% 0.93% -397.31% 138.26% 7.27%
Invested Capital Q/Q Growth		 -7.27% -8.83% -26.14% -0.72% 59.09% 0.41% 2.99% 2.20% 44.41% -3.09% -4.46%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 77.23% 75.25% 75.55% 74.45% 73.85% 74.55% 73.26% 71.75% 71.79% 68.43% 66.92%
EBITDA Margin		 30.65% 32.20% 35.78% 29.95% 23.10% 24.87% 32.53% 26.69% 17.30% 16.46% 19.70%
Operating Margin		 26.97% 29.10% 33.79% 27.43% 19.65% 21.03% 30.38% 24.47% 15.61% 12.58% 16.35%
EBIT Margin		 27.36% 29.28% 33.54% 27.27% 19.75% 21.44% 30.11% 24.25% 14.48% 12.85% 16.68%
Profit (Net Income) Margin		 41.52% 27.14% 23.07% 27.19% 28.10% 21.72% 26.99% 21.42% 13.52% 11.61% 11.51%
Tax Burden Percent		 147.35% 88.66% 66.32% 93.47% 125.08% 94.26% 87.76% 85.97% 83.66% 80.75% 62.60%
Interest Burden Percent		 102.98% 104.54% 103.71% 106.69% 113.74% 107.47% 102.13% 102.75% 111.62% 111.89% 110.22%
Effective Tax Rate		 15.20% 11.18% 33.68% 6.53% -25.08% 5.74% 12.24% 14.03% 16.34% 19.25% 37.40%
Return on Invested Capital (ROIC)		 54.82% 64.92% 70.77% 68.29% 42.06% 31.99% 54.36% 38.25% 14.46% 10.00% 11.43%
ROIC Less NNEP Spread (ROIC-NNEP)		 40.65% 63.91% 70.13% 66.75% 38.96% 30.07% 53.96% 37.81% 13.91% 7.72% 9.37%
Return on Net Nonoperating Assets (RNNOA)		 -30.87% -48.85% -53.60% -48.64% -25.70% -18.53% -33.57% -23.22% -6.76% -2.97% -3.83%
Return on Equity (ROE)		 23.95% 16.07% 17.17% 19.66% 16.37% 13.46% 20.79% 15.03% 7.69% 7.03% 7.61%
Cash Return on Invested Capital (CROIC)		 37.63% 58.61% 50.05% 45.18% 1.34% 35.09% 48.86% 27.15% -31.07% 9.82% 20.53%
Operating Return on Assets (OROA)		 14.42% 16.10% 22.09% 17.06% 9.03% 9.44% 16.41% 12.32% 6.10% 5.86% 8.27%
Return on Assets (ROA)		 21.89% 14.92% 15.19% 17.01% 12.84% 9.56% 14.71% 10.88% 5.70% 5.29% 5.71%
Return on Common Equity (ROCE)		 23.95% 16.07% 17.17% 19.66% 16.37% 13.46% 20.79% 15.03% 7.69% 7.03% 7.61%
Return on Equity Simple (ROE_SIMPLE)		 22.66% 14.93% 16.13% 19.31% 15.04% 13.96% 19.57% 14.98% 7.53% 7.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 103 137 172 207 178 161 277 212 109 93 102
NOPAT Margin		 22.87% 25.84% 22.41% 25.64% 24.58% 19.82% 26.67% 21.04% 13.06% 10.16% 10.24%
Net Nonoperating Expense Percent (NNEP)		 14.17% 1.00% 0.64% 1.54% 3.10% 1.91% 0.40% 0.44% 0.54% 2.28% 2.06%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - 14.72% 7.27% 6.12% 6.82%
Cost of Revenue to Revenue		 22.77% 24.75% 24.45% 25.55% 26.15% 25.45% 26.74% 28.25% 28.21% 31.57% 33.08%
SG&A Expenses to Revenue		 34.77% 31.37% 28.81% 32.58% 37.74% 32.99% 29.83% 31.02% 40.49% 40.56% 36.59%
R&D to Revenue		 15.49% 14.78% 12.95% 14.44% 16.46% 16.15% 13.05% 14.03% 16.64% 15.29% 13.98%
Operating Expenses to Revenue		 50.26% 46.15% 41.76% 47.02% 54.20% 53.52% 42.88% 47.28% 56.18% 55.85% 50.57%
Earnings before Interest and Taxes (EBIT)		 123 155 257 220 143 174 312 244 121 118 166
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 138 170 274 242 168 202 337 269 145 151 196
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 3.24 5.32 9.12 5.55 6.72 10.89 9.45 5.59 4.74 4.05 4.04
Price to Tangible Book Value (P/TBV)		 3.63 5.96 10.31 6.23 8.49 13.71 11.49 6.79 7.14 5.90 5.89
Price to Revenue (P/Rev)		 5.94 9.68 13.04 7.82 12.55 16.95 13.03 7.99 8.52 6.73 6.06
Price to Earnings (P/E)		 14.31 35.66 56.53 28.76 44.67 78.01 48.30 37.28 62.99 57.93 52.69
Dividend Yield		 0.67% 0.49% 0.00% 0.51% 0.38% 2.83% 2.94% 0.57% 0.69% 0.85% 0.90%
Earnings Yield		 6.99% 2.80% 1.77% 3.48% 2.24% 1.28% 2.07% 2.68% 1.59% 1.73% 1.90%
Enterprise Value to Invested Capital (EV/IC)		 10.07 20.14 34.23 16.31 16.19 26.23 24.12 12.29 7.06 5.98 6.34
Enterprise Value to Revenue (EV/Rev)		 4.56 8.27 11.96 6.83 11.39 16.00 12.16 7.14 7.83 6.08 5.42
Enterprise Value to EBITDA (EV/EBITDA)		 14.88 25.68 33.43 22.80 49.30 64.34 37.37 26.74 45.25 36.96 27.50
Enterprise Value to EBIT (EV/EBIT)		 16.67 28.24 35.66 25.05 57.65 74.61 40.39 29.43 54.07 47.34 32.49
Enterprise Value to NOPAT (EV/NOPAT)		 19.94 32.00 53.37 26.64 46.32 80.73 45.60 33.93 59.95 59.88 52.94
Enterprise Value to Operating Cash Flow (EV/OCF)		 16.01 24.05 40.84 24.65 32.62 53.53 40.15 29.50 58.06 37.32 21.95
Enterprise Value to Free Cash Flow (EV/FCFF)		 29.05 35.44 75.47 40.28 1,457.96 73.59 50.73 47.79 0.00 60.99 29.49
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -0.76 -0.76 -0.76 -0.73 -0.66 -0.62 -0.62 -0.61 -0.49 -0.39 -0.41
Leverage Ratio		 1.09 1.08 1.13 1.16 1.27 1.41 1.41 1.38 1.35 1.33 1.33
Compound Leverage Factor		 1.13 1.13 1.17 1.23 1.45 1.51 1.44 1.42 1.51 1.48 1.47
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 28.25 42.85 33.67 27.03 11.81 16.78 15.84 10.90 9.62 9.04 8.25
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 8.28 8.00 5.59 8.54 5.04 4.55 3.39 3.82 4.47 3.62 3.80
Quick Ratio		 7.29 7.27 4.72 7.26 4.32 3.81 2.43 2.81 2.95 2.32 2.73
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 71 124 121 137 5.67 176 249 150 -235 91 183
Operating Cash Flow to CapEx		 704.01% 1,420.73% 780.15% 602.38% 1,164.92% 1,822.15% 2,032.13% 1,237.64% 489.30% 991.03% 2,808.12%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.53 0.55 0.66 0.63 0.46 0.44 0.55 0.51 0.42 0.46 0.50
Accounts Receivable Turnover		 10.87 10.54 8.30 6.34 6.16 6.77 7.81 7.68 6.86 6.96 6.41
Inventory Turnover		 3.08 4.08 3.95 2.73 2.64 3.41 3.19 2.41 1.66 1.81 2.23
Fixed Asset Turnover		 9.08 9.87 11.60 9.52 8.03 9.62 13.24 12.80 9.03 8.95 10.78
Accounts Payable Turnover		 8.18 14.82 11.25 10.38 11.13 12.09 9.19 7.99 9.73 9.70 7.46
Days Sales Outstanding (DSO)		 33.59 34.65 43.95 57.56 59.28 53.91 46.75 47.51 53.20 52.48 56.92
Days Inventory Outstanding (DIO)		 118.42 89.56 92.48 133.92 138.06 107.06 114.48 151.29 219.93 202.15 163.89
Days Payable Outstanding (DPO)		 44.63 24.63 32.44 35.16 32.79 30.18 39.70 45.69 37.50 37.61 48.96
Cash Conversion Cycle (CCC)		 107.38 99.57 103.99 156.33 164.55 130.78 121.53 153.11 235.63 217.02 171.85
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 204 217 268 338 510 495 523 584 928 930 850
Invested Capital Turnover		 2.40 2.51 3.16 2.66 1.71 1.61 2.04 1.82 1.11 0.98 1.12
Increase / (Decrease) in Invested Capital		 32 13 50 70 173 -16 28 61 344 1.68 -81
Enterprise Value (EV)		 2,055 4,378 9,162 5,507 8,262 12,977 12,610 7,182 6,556 5,564 5,388
Market Capitalization		 2,677 5,124 9,990 6,305 9,107 13,744 13,518 8,036 7,132 6,151 6,030
Book Value per Share		 $9.73 $11.24 $12.65 $6.59 $7.93 $7.23 $8.09 $8.32 $8.74 $8.85 $8.90
Tangible Book Value per Share		 $8.70 $10.03 $11.19 $5.88 $6.28 $5.74 $6.65 $6.84 $5.80 $6.07 $6.11
Total Capital		 826 963 1,096 1,135 1,356 1,262 1,430 1,438 1,505 1,518 1,492
Total Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -622 -745 -828 -798 -845 -767 -907 -854 -576 -587 -642
Capital Expenditures (CapEx)		 18 13 29 37 22 13 15 20 23 15 8.74
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 42 40 113 153 75 97 128 130 195 198 177
Debt-free Net Working Capital (DFNWC)		 391 461 517 689 487 469 451 530 527 444 514
Net Working Capital (NWC)		 391 461 517 689 487 469 451 530 527 444 514
Net Nonoperating Expense (NNE)		 -84 -6.86 -5.04 -13 -26 -15 -3.33 -3.84 -3.89 -13 -13
Net Nonoperating Obligations (NNO)		 -622 -745 -828 -798 -845 -767 -907 -854 -576 -587 -642
Total Depreciation and Amortization (D&A)		 15 15 17 22 24 28 25 25 24 33 30
Debt-free, Cash-free Net Working Capital to Revenue		 9.40% 7.50% 14.73% 19.03% 10.32% 11.97% 12.30% 12.91% 23.29% 21.64% 17.77%
Debt-free Net Working Capital to Revenue		 86.74% 86.98% 67.53% 85.44% 67.08% 57.88% 43.51% 52.68% 62.94% 48.55% 51.66%
Net Working Capital to Revenue		 86.74% 86.98% 67.53% 85.44% 67.08% 57.88% 43.51% 52.68% 62.94% 48.55% 51.66%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $1.09 $0.88 $1.02 $1.27 $1.19 $1.02 $1.59 $1.24 $0.66 $0.62 $0.68
Adjusted Weighted Average Basic Shares Outstanding		 172.59M 170.68M 173.29M 172.33M 171.19M 173.49M 176.46M 173.41M 172.25M 171.44M 168.05M
Adjusted Diluted Earnings per Share		 $1.07 $0.86 $0.99 $1.24 $1.16 $1.00 $1.56 $1.23 $0.65 $0.62 $0.68
Adjusted Weighted Average Diluted Shares Outstanding		 175.98M 174.14M 179.55M 177.41M 175.27M 176.59M 179.92M 174.87M 173.40M 172.61M 169.37M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 169.77M 172.11M 173.55M 170.83M 172.61M 352.06M 347.83M 345.07M 343.27M 169.87M 165.71M
Normalized Net Operating Profit after Tax (NOPAT)		 103 137 172 207 100 194 277 213 109 93 102
Normalized NOPAT Margin		 22.87% 25.84% 22.41% 25.64% 13.76% 23.95% 26.67% 21.18% 13.06% 10.16% 10.24%
Pre Tax Income Margin		 28.18% 30.61% 34.78% 29.09% 22.46% 23.05% 30.75% 24.92% 16.16% 14.38% 18.38%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 9.66% 17.55% 16.43% 14.53% 17.23% 221.65% 15.46% 21.31% 43.34% 49.29% 47.73%
Augmented Payout Ratio		 77.20% 50.36% 86.44% 107.49% 47.49% 250.61% 73.22% 116.10% 113.81% 112.47% 180.22%

Quarterly Metrics And Ratios for Cognex

This table displays calculated financial ratios and metrics derived from Cognex's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 10/1/2023 12/31/2023 3/31/2024 6/30/2024 9/29/2024 12/31/2024 3/30/2025 6/29/2025 9/28/2025 12/31/2025 4/5/2026
DEI Shares Outstanding		 - - - - - - - - - - 165,707,920.00
DEI Adjusted Shares Outstanding		 - - - - - - - - - - 165,707,920.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - - - 0.31
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -5.91% -17.86% 4.81% -1.33% 19.01% 16.79% 2.49% 4.10% 17.96% 9.86% 24.26%
EBITDA Growth		 -37.85% -67.99% -19.15% -32.54% 52.25% 95.53% 38.25% 11.24% 58.50% 17.88% 102.12%
EBIT Growth		 -41.70% -77.45% -36.16% -39.62% 49.22% 146.42% 64.81% 14.49% 77.81% 24.44% 139.08%
NOPAT Growth		 -37.91% -80.38% -55.11% -39.38% 19.05% 145.22% 127.90% 9.28% -36.47% 7.05% 126.26%
Net Income Growth		 -44.33% -79.70% -53.07% -36.99% 56.43% 152.44% 96.33% 11.87% -40.31% 15.23% 119.06%
EPS Growth		 -42.11% -81.25% -53.33% -36.36% 54.55% 183.33% 100.00% 14.29% -41.18% 17.65% 121.43%
Operating Cash Flow Growth		 -50.88% -78.13% -50.48% -6.99% 37.17% 254.73% 196.87% 53.53% 55.47% 45.71% 11.34%
Free Cash Flow Firm Growth		 -69.48% -3,032.56% -1,880.02% -3,046.33% -483.77% 106.80% 106.82% 112.80% 129.79% 379.47% 476.43%
Invested Capital Growth		 12.49% 58.95% 54.80% 46.83% 49.29% 0.18% 0.03% 0.22% -7.35% -8.70% -8.13%
Revenue Q/Q Growth		 -18.67% -0.29% 7.18% 13.52% -1.90% -2.15% -5.94% 15.30% 11.16% -8.87% 6.38%
EBITDA Q/Q Growth		 -60.38% -26.49% 13.50% 104.11% -10.60% -5.60% -19.75% 64.24% 27.39% -29.79% 38.29%
EBIT Q/Q Growth		 -65.28% -41.96% 12.56% 166.18% -14.19% -4.15% -24.72% 84.90% 33.27% -32.92% 44.63%
NOPAT Q/Q Growth		 -61.17% -53.60% -2.38% 244.63% -23.73% -4.43% -9.27% 65.25% -55.66% 61.05% 91.76%
Net Income Q/Q Growth		 -67.09% -40.64% 7.06% 201.21% -18.28% -4.21% -16.73% 71.64% -56.40% 84.92% 58.29%
EPS Q/Q Growth		 -66.67% -45.45% 16.67% 200.00% -19.05% 0.00% -17.65% 71.43% -58.33% 100.00% 55.00%
Operating Cash Flow Q/Q Growth		 37.44% -64.68% -5.85% 103.50% 102.68% -8.65% -21.21% 5.24% 105.24% -14.38% -39.80%
Free Cash Flow Firm Q/Q Growth		 -644.76% -569.97% 4.17% 15.76% -7.94% 107.80% -3.88% 58.07% 151.27% 23.38% 17.62%
Invested Capital Q/Q Growth		 -0.78% 44.41% 0.44% 2.02% 0.89% -3.09% 0.29% 2.21% -6.73% -4.46% 0.87%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 72.39% 68.67% 67.33% 69.62% 67.90% 68.73% 66.81% 67.39% 67.64% 65.75% 71.13%
EBITDA Margin		 13.88% 10.23% 10.84% 19.49% 17.76% 17.13% 14.62% 20.82% 23.86% 18.38% 23.90%
Operating Margin		 15.53% 6.47% 6.74% 16.07% 13.45% 13.43% 12.08% 17.44% 20.86% 13.98% 22.30%
EBIT Margin		 11.21% 6.53% 6.85% 16.07% 14.06% 13.77% 11.02% 17.67% 21.19% 15.60% 21.20%
Profit (Net Income) Margin		 9.59% 5.71% 5.70% 15.13% 12.61% 12.34% 10.93% 16.26% 6.38% 12.94% 19.26%
Tax Burden Percent		 70.05% 78.23% 68.44% 87.12% 80.95% 79.18% 84.91% 84.29% 28.10% 74.10% 83.72%
Interest Burden Percent		 122.12% 111.84% 121.60% 108.10% 110.79% 113.20% 116.76% 109.18% 107.15% 112.00% 108.50%
Effective Tax Rate		 29.95% 21.77% 31.56% 12.88% 19.05% 20.82% 15.09% 15.71% 71.90% 25.90% 16.28%
Return on Invested Capital (ROIC)		 15.77% 5.61% 5.09% 14.78% 11.97% 10.46% 10.11% 14.34% 6.16% 11.57% 21.84%
ROIC Less NNEP Spread (ROIC-NNEP)		 16.08% 5.43% 4.76% 14.38% 11.42% 9.79% 9.84% 13.64% 5.92% 10.51% 21.56%
Return on Net Nonoperating Assets (RNNOA)		 -9.29% -2.64% -2.27% -6.68% -5.43% -3.77% -3.59% -5.02% -2.34% -4.29% -8.37%
Return on Equity (ROE)		 6.48% 2.97% 2.82% 8.09% 6.54% 6.69% 6.53% 9.33% 3.82% 7.28% 13.48%
Cash Return on Invested Capital (CROIC)		 13.01% -31.07% -30.44% -28.58% -29.75% 9.82% 11.28% 11.19% 18.42% 20.53% 22.90%
Operating Return on Assets (OROA)		 5.07% 2.75% 2.91% 6.78% 6.11% 6.28% 5.14% 8.20% 10.13% 7.74% 11.27%
Return on Assets (ROA)		 4.34% 2.41% 2.42% 6.38% 5.48% 5.63% 5.09% 7.54% 3.05% 6.42% 10.24%
Return on Common Equity (ROCE)		 6.48% 2.97% 2.82% 8.09% 6.54% 6.69% 6.53% 9.33% 3.82% 7.28% 13.48%
Return on Equity Simple (ROE_SIMPLE)		 10.57% 0.00% 6.69% 5.20% 5.68% 0.00% 8.15% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 21 9.96 9.72 34 26 24 22 37 16 26 50
NOPAT Margin		 10.88% 5.06% 4.61% 14.00% 10.88% 10.63% 10.26% 14.70% 5.86% 10.36% 18.67%
Net Nonoperating Expense Percent (NNEP)		 -0.31% 0.18% 0.33% 0.39% 0.56% 0.68% 0.27% 0.70% 0.24% 1.06% 0.28%
Return On Investment Capital (ROIC_SIMPLE)		 - 0.66% - - - 1.61% 1.53% 2.43% 1.09% 1.75% 3.39%
Cost of Revenue to Revenue		 27.61% 31.33% 32.67% 30.38% 32.10% 31.27% 33.19% 32.61% 32.36% 34.25% 28.87%
SG&A Expenses to Revenue		 41.73% 45.95% 42.99% 38.94% 39.46% 41.14% 38.65% 36.67% 34.11% 37.48% 35.03%
R&D to Revenue		 16.52% 17.64% 17.60% 14.61% 15.00% 14.17% 16.07% 13.29% 12.67% 14.29% 13.79%
Operating Expenses to Revenue		 56.85% 62.19% 60.60% 53.55% 54.46% 55.30% 54.73% 49.96% 46.78% 51.77% 48.83%
Earnings before Interest and Taxes (EBIT)		 22 13 14 38 33 32 24 44 59 39 57
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 27 20 23 47 42 39 32 52 66 46 64
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 4.88 4.74 4.89 5.32 4.41 4.05 3.53 3.51 5.16 4.04 5.51
Price to Tangible Book Value (P/TBV)		 5.86 7.14 7.29 7.80 6.44 5.90 5.28 5.20 7.61 5.89 7.92
Price to Revenue (P/Rev)		 8.24 8.52 8.59 9.49 7.83 6.73 5.54 5.68 7.91 6.06 7.78
Price to Earnings (P/E)		 46.13 62.99 73.03 102.21 77.55 57.93 43.29 43.27 69.81 52.69 57.16
Dividend Yield		 0.66% 0.69% 0.69% 0.63% 0.75% 0.85% 1.03% 1.00% 0.70% 0.90% 0.67%
Earnings Yield		 2.17% 1.59% 1.37% 0.98% 1.29% 1.73% 2.31% 2.31% 1.43% 1.90% 1.75%
Enterprise Value to Invested Capital (EV/IC)		 9.97 7.06 7.21 7.84 6.56 5.98 4.91 4.96 7.97 6.34 8.78
Enterprise Value to Revenue (EV/Rev)		 7.28 7.83 7.93 8.83 7.15 6.08 4.98 5.09 7.29 5.42 7.19
Enterprise Value to EBITDA (EV/EBITDA)		 34.17 45.25 48.18 63.74 47.98 36.96 28.79 28.75 37.53 27.50 32.96
Enterprise Value to EBIT (EV/EBIT)		 38.78 54.07 59.43 84.88 63.80 47.34 36.14 35.70 44.82 32.49 37.83
Enterprise Value to NOPAT (EV/NOPAT)		 42.63 59.95 69.61 99.55 80.28 59.88 43.47 43.52 71.03 52.94 58.29
Enterprise Value to Operating Cash Flow (EV/OCF)		 38.93 58.06 67.87 76.93 56.16 37.32 26.06 24.78 31.92 21.95 30.09
Enterprise Value to Free Cash Flow (EV/FCFF)		 81.13 0.00 0.00 0.00 0.00 60.99 43.59 44.37 41.61 29.49 36.72
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -0.58 -0.49 -0.48 -0.46 -0.48 -0.39 -0.36 -0.37 -0.40 -0.41 -0.39
Leverage Ratio		 1.35 1.35 1.36 1.34 1.33 1.33 1.34 1.33 1.33 1.33 1.35
Compound Leverage Factor		 1.65 1.51 1.65 1.45 1.47 1.50 1.57 1.45 1.43 1.49 1.46
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 9.95 9.45 9.41 10.82 9.48 8.89 7.34 7.47 10.16 8.04 10.44
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 4.99 4.47 3.52 4.03 3.94 3.62 3.14 3.29 3.96 3.80 3.64
Quick Ratio		 3.80 2.95 2.23 2.67 2.62 2.32 1.98 2.18 2.79 2.73 2.55
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -50 -334 -320 -270 -291 23 22 35 87 107 126
Operating Cash Flow to CapEx		 700.65% 206.57% 335.95% 615.59% 1,279.18% 2,479.69% 1,619.43% 1,942.80% 6,025.14% 2,885.29% 1,635.58%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.45 0.42 0.43 0.42 0.44 0.46 0.47 0.46 0.48 0.50 0.53
Accounts Receivable Turnover		 7.64 6.86 5.89 5.42 6.03 6.96 6.03 5.35 5.86 6.41 5.96
Inventory Turnover		 2.02 1.66 1.66 1.82 1.93 1.81 1.81 1.99 2.10 2.23 2.33
Fixed Asset Turnover		 10.84 9.03 9.14 9.14 9.47 8.95 9.19 9.46 10.07 10.78 11.61
Accounts Payable Turnover		 10.80 9.73 9.11 10.58 10.50 9.70 8.24 9.25 8.33 7.46 6.51
Days Sales Outstanding (DSO)		 47.80 53.20 62.00 67.31 60.50 52.48 60.57 68.18 62.28 56.92 61.21
Days Inventory Outstanding (DIO)		 180.91 219.93 219.50 200.80 189.46 202.15 202.16 183.55 173.56 163.89 156.83
Days Payable Outstanding (DPO)		 33.79 37.50 40.07 34.51 34.75 37.61 44.29 39.46 43.81 48.96 56.07
Cash Conversion Cycle (CCC)		 194.92 235.63 241.43 233.59 215.21 217.02 218.43 212.28 192.03 171.85 161.96
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 643 928 933 951 960 930 933 954 889 850 857
Invested Capital Turnover		 1.45 1.11 1.10 1.06 1.10 0.98 0.99 0.98 1.05 1.12 1.17
Increase / (Decrease) in Invested Capital		 71 344 330 303 317 1.68 0.30 2.07 -71 -81 -76
Enterprise Value (EV)		 6,412 6,556 6,720 7,456 6,299 5,564 4,585 4,728 7,088 5,388 7,526
Market Capitalization		 7,258 7,132 7,276 8,011 6,906 6,151 5,098 5,281 7,688 6,030 8,148
Book Value per Share		 $8.64 $8.74 $8.67 $8.78 $9.14 $8.85 $8.51 $8.97 $8.87 $8.90 $8.93
Tangible Book Value per Share		 $7.18 $5.80 $5.81 $5.98 $6.26 $6.07 $5.68 $6.06 $6.02 $6.11 $6.21
Total Capital		 1,489 1,505 1,489 1,507 1,567 1,518 1,446 1,506 1,490 1,492 1,479
Total Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -846 -576 -557 -555 -607 -587 -513 -553 -600 -642 -622
Capital Expenditures (CapEx)		 5.86 7.02 4.06 4.51 4.40 2.07 2.50 2.19 1.45 2.60 2.76
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 165 195 195 223 213 198 193 207 201 177 204
Debt-free Net Working Capital (DFNWC)		 677 527 473 512 501 444 394 435 502 514 501
Net Working Capital (NWC)		 677 527 473 512 501 444 394 435 502 514 501
Net Nonoperating Expense (NNE)		 2.55 -1.27 -2.30 -2.71 -4.04 -3.93 -1.45 -3.90 -1.43 -6.52 -1.58
Net Nonoperating Obligations (NNO)		 -846 -576 -557 -555 -607 -587 -513 -553 -600 -642 -622
Total Depreciation and Amortization (D&A)		 5.27 7.29 8.40 8.18 8.69 7.73 7.77 7.85 7.41 7.04 7.24
Debt-free, Cash-free Net Working Capital to Revenue		 18.70% 23.29% 23.04% 26.44% 24.22% 21.64% 21.01% 22.28% 20.72% 17.77% 19.50%
Debt-free Net Working Capital to Revenue		 76.94% 62.94% 55.88% 60.69% 56.87% 48.55% 42.81% 46.83% 51.63% 51.66% 47.85%
Net Working Capital to Revenue		 76.94% 62.94% 55.88% 60.69% 56.87% 48.55% 42.81% 46.83% 51.63% 51.66% 47.85%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.11 $0.07 $0.07 $0.21 $0.17 $0.17 $0.14 $0.24 $0.11 $0.19 $0.31
Adjusted Weighted Average Basic Shares Outstanding		 172.17M 172.25M 171.69M 171.57M 171.52M 171.44M 169.27M 167.89M 167.84M 168.05M 166.51M
Adjusted Diluted Earnings per Share		 $0.11 $0.06 $0.07 $0.21 $0.17 $0.17 $0.14 $0.24 $0.10 $0.20 $0.31
Adjusted Weighted Average Diluted Shares Outstanding		 173.35M 173.40M 172.59M 172.73M 172.75M 172.61M 170.39M 168.56M 169.32M 169.37M 168.39M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 172.14M 343.27M 171.66M 171.50M 171.52M 169.87M 167.86M 167.90M 167.60M 165.71M 166.42M
Normalized Net Operating Profit after Tax (NOPAT)		 21 9.96 9.72 34 26 24 22 37 40 26 50
Normalized NOPAT Margin		 10.88% 5.06% 4.61% 14.00% 10.88% 10.63% 10.26% 14.70% 14.60% 10.36% 18.67%
Pre Tax Income Margin		 13.69% 7.30% 8.33% 17.37% 15.57% 15.59% 12.87% 19.29% 22.70% 17.47% 23.01%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 30.70% 43.34% 50.06% 64.65% 57.82% 49.29% 45.00% 43.88% 49.16% 47.73% 38.78%
Augmented Payout Ratio		 85.09% 113.81% 115.24% 129.10% 107.22% 112.47% 180.86% 166.32% 203.41% 180.22% 142.87%

Financials Breakdown Chart

Key Financial Trends

Here is a concise, investor‑focused take on Cognex (CGNX) using the quarterly figures provided for the last four years. The highlights focus on revenue, margins, cash flow, and balance‑sheet health, with a quick read on liquidity and capital allocation.

  • Revenue has trended up across 2025, with Q4 2025 at $252.3 million (vs. $229.7 million in Q4 2024) and Q3 2025 at $276.9 million, signaling a multi‑quarter uptrend in top line.
  • Gross margin has remained strong and relatively stable in the mid‑60s to high‑60s percent range (about 66%–68% in 2025), indicating solid pricing power and cost control.
  • Operating cash flow was robust in 2025, with notable reads of about $87.5 million in Q3 and $74.9 million in Q4, improving versus the $51.4 million level in 2024 Q4.
  • The balance sheet remains solid, with Total Assets near $2.0 billion and Total Equity around $1.5 billion; cash on hand rose to roughly $246 million by Q3 2025, and leverage remains minimal.
  • Earnings per share show improvement in 2025, with Q4 2025 Basic EPS of $0.19 and Diluted EPS of $0.20, and Q2 2025 EPS at $0.24, reflecting a favorable trend in profitability.
  • Free cash flow was positive in Q4 2025 (approx. $74.9 million operating cash flow minus around $2.6 million for capex), underscoring strong cash‑generation efficiency.
  • Dividend per share remains at $0.08, indicating a steady, shareholder‑friendly payout policy without a dramatic increase or cut.
  • G&A and R&D spend stayed relatively steady (SG&A around $90–95 million; R&D around $34–37 million in 2025), suggesting disciplined cost management without dramatic swings.
  • Financing activities show negative cash flow in multiple 2025 quarters due to stock buybacks and dividends, which press on near‑term liquidity despite strong operating cash flow.
05/27/26 03:46 AM ETAI Generated. May Contain Errors.

Cognex Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Cognex's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Cognex's net income appears to be on a downward trend, with a most recent value of $114.44 million in 2025, falling from $187.07 million in 2015. The previous period was $106.17 million in 2024. Check out Cognex's forecast to explore projected trends and price targets.

Cognex's total operating income in 2025 was $162.57 million, based on the following breakdown:
  • Total Gross Profit: $665.39 million
  • Total Operating Expenses: $502.83 million

Over the last 10 years, Cognex's total revenue changed from $450.56 million in 2015 to $994.36 million in 2025, a change of 120.7%.

Cognex's total liabilities were at $524.65 million at the end of 2025, a 10.4% increase from 2024, and a 745.0% increase since 2015.

In the past 10 years, Cognex's cash and equivalents has ranged from $51.98 million in 2015 to $269.07 million in 2020, and is currently $262.93 million as of their latest financial filing in 2025.

Over the last 10 years, Cognex's book value per share changed from 9.73 in 2015 to 8.90 in 2025, a change of -8.5%.


Related Companies

Financial statements for NASDAQ:CGNX last updated on 5/8/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Read now. Do not delete. You’ve been warned.
Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” P...
Porter & Company | Sponsoredtc pixel
SpaceX IPO hides a much bigger story
The SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...
Weiss Ratings | Sponsoredtc pixel
SpaceX will mint billionaires. You won't be one of them.
By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...
Behind the Markets | Sponsoredtc pixel
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel